PREVALENCE OF THALASSEMIA TRAIT AMONG INDIVIDUALS AT RISK IN NAWABSHAH: A CROSS-SECTIONAL STUDY
Main Article Content
Keywords
Thalassemia, Nawabshah, anemia, MCH, prevalence
Abstract
Background: Thalassemia is a genetic condition characterized by an inability to properly produce alpha and beta hemoglobin components.
Aim of study: To determine how often the thalassemia trait occurs among healthy people in Nawabshah.
Methods: This study was conducted at the People’s University of Medical and Health Sciences, Nawabshah, between Aug 2024 and Dec 2024. Individuals referred by physicians for thalassemia screening were directed to the Outpatient Department (OPD) for testing. A total of 2315 individuals underwent screening, out of which 216 individuals who tested positive for the thalassemia trait and were confirmed by physicians were included in the final analysis.
Results: Thalassemia screening included 2315 participants. Of the total, 7.2% (n = 166) tested positive for thalassemia traits during screening. In our study population, beta-thalassemia was the most common (84.60%, n=141), followed by HbE thalassemia (11.50%, n=48), whereas alpha-thalassemia was the least prevalent, accounting for 3.90% (n=16) of the cases. Of the thalassemia cases, 81.9% were associated with consanguineous marriages, indicating a significant prevalence of intrafamilial unions among affected individuals. Conversely, 18.1% of the cases were linked to exogamous marriages, demonstrating a smaller proportion of cases arising from marriages outside the family.
Conclusion: This study demonstrated that β-thalassemia was the predominant subtype among patients with thalassemia in the screened population. A significantly elevated prevalence of consanguineous marriages has been identified as the primary etiological factor contributing to thalassemia in Nawabshah.
References
2. Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med. 2005 Sep 15;353(11):1135–46.
3. Langer AL. Beta-thalassemia. 2021 [cited 2025 Feb 2]; Available from: https://europepmc.org/books/nbk1426/
4. Lorey FW, Arnopp J, Cunningham GC. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state. Genet Epidemiol. 1996;13(5):501–12.
5. Vetter B, Schwarz C, Kohne E, Kulozik AE. Beta‐thalassaemia in the immigrant and non‐immigrant German populations. Br J Haematol. 1997 May;97(2):266–72.
6. Population Reference Bureau. Washington, DC, USA: PRB (cited 6 Apr 2017). Available from http://www.prb.org/ Publications/Datasheets/2012/2012-world-population-data-sheet. 2017;
7. Pethe N, Munemane A, Dongre S. Determination of frequency of thalassaemia trait in a rural tertiary care hospital of India by using various red cell indices as screening tool. Ann Pathol Lab Med. 2015;2(2):A70-74.
8. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol. 2007;29(4):233–8.
9. Madan N, Sharma S, Sood SK, Colah R. Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet. 2010;16(1):16.
10. Wong LP, George E, Tan JAMA. Public perceptions and attitudes toward thalassaemia: Influencing factors in a multi-racial population. BMC Public Health. 2011 Dec;11(1):193.
11. Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin. 1987 Jan;11(1):65–88.
12. Population Reference Bureau. Washington, DC, USA: PRB (cited 21 Apr 2011). Available from http://www.prb.org/.
13. Baig SM, Azhar A, Hassan H, Baig JM, Kiyani A, Hameed U, et al. Spectrum of beta-thalassemia mutations in various regions of Punjab and Islamabad, Pakistan: establishment of prenatal diagnosis. haematologica. 2006;91(3):ELT02–ELT02.
14. Lodhi Y. Economics of thalassemia management in Pakistan. Thalass Aware Week. 2003;
15. Ghani R, Manji MA, Ahmed N. Hemoglobinopathies among five major ethnic groups in Karachi, Pakistan. Southeast Asian J Trop Med Public Health. 2002;33(4):855–61.
16. Khattak MF, Saleem M. Prevalence of heterozygous beta-thalassemia in northern areas of Pakistan. JPMA J Pak Med Assoc. 1992;42(2):32–4.
17. Baig SM. Molecular diagnosis of beta-thalassemia by multiplex ARMS-PCR: a cost effective method for developing countries like Pakistan. Prenat Diagn. 2007;27(6):580–1.
18. Suhaib Ahmed SA, Mohammed Saleem MS, Modell B, Petrou M. Screening extended families for genetic hemoglobin disorders in Pakistan. 2002 [cited 2025 Feb 2]; Available from: https://www.cabidigitallibrary.org/doi/full/10.5555/20023157831
19. Khan SN, Hasan F, Sollaino C, Perseu L, Riazuddin S. Molecular Characterization of α‐Thalassemia in Pakistan. Hemoglobin. 2003 Jan;27(3):161–6.
20. Mohanty D, Colah RB, Gorakshakar AC, Patel RZ, Master DC, Mahanta J, et al. Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. J Community Genet. 2013 Jan;4(1):33–42.
21. Jain P, Gupta M, Dua S, Marwah N, Gill M, Sen R. Prevalence of Various Hemoglobinopathies-An Experience from Tertiary Care Centre. Dicle Tip Derg. 2019;46(2):269–76.
22. Goh LPW, Chong ETJ, Lee PC. Prevalence of alpha (α)-thalassemia in Southeast Asia (2010–2020): A meta-analysis involving 83,674 subjects. Int J Environ Res Public Health. 2020;17(20):7354.
23. Kulaphisit M, Kampuansai J, Leecharoenkiat K, Wathikthinnakon M, Kangwanpong D, Munkongdee T, et al. A comprehensive ethnic-based analysis of alpha thalassaemia allelle frequency in northern Thailand. Sci Rep. 2017;7(1):4690.
24. Lai K, Huang G, Su L, He Y. The prevalence of thalassemia in mainland China: evidence from epidemiological surveys. Sci Rep. 2017;7(1):920.
25. Olivieri NF, Pakbaz Z, Vichinsky E. Hb E/beta-thalassaemia: a common & clinically diverse disorder. Indian J Med Res. 2011;134(4):522–31.
26. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–7.
27. Colah R, Italia K, Gorakshakar A. Burden of thalassemia in India: the road map for control. Pediatr Hematol Oncol J. 2017;2(4):79–84.
28. Aslamkhan M, Qadeer MI, Akhtar MS, Chudhary SA, Mariam M, Ali Z, et al. CULTURAL CONSANGUINITY AS CAUSE OF β-THALASSEMIA PREVALENCE IN POPULATION. medRxiv. 2023;2023–06.
29. Masih N, Amir F, Tabbasum R, Naz A, Nadeem A. An Empirical Investigation of the Relationship Between Consanguineous Marriage and Prevalence of B-thalassemia in Punjab, Pakistan: A Cross-sectional Study. Int J Health Sci. 7(S1):2362–7.
30. Bittles A. Consanguinity and its relevance to clinical genetics. Clin Genet. 2001 Aug;60(2):89–98.
31. Weatherall DJ, Clegg JB. The thalassaemia syndromes [Internet]. John Wiley & Sons; 2008 [cited 2025 Feb 2]. Available from:
https://books.google.com.pk/books?hl=en&lr=&id=Jao0z6R4R5gC&oi=fnd&pg=PR5&dq=Weatherall,+D.+J.,+%26+Clegg,+J.+B.+(2001).+The+Thalassaemia+Syndromes+(4th+ed.).+Blackwell+Science.&ots=npXiME-UMI&sig=XrwPzPk_JwQl4KUmG_9cPSq2WK0
32. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010 Dec;5(1):11.

